Abstract
Objectives: This study aims to report the clinical efficacy of Korean medical treatment of a patient with nonalcoholic fatty liver disease accompanied by obesity and dyslipidemia.Methods: A 52-year-old man with nonalcoholic fatty liver disease, obesity, and dyslipidemia was treated with <i>Saenggangunbi-tang</i> extract from November 3, 2021 to January 8, 2022. During the treatment period, the patient also undertook exercise and maintained a hypocaloric diet to reduce body weight. Changes were observed in the patient’s symptoms, laboratory findings, such as liver enzymes and lipid profiles, and bioelectrical impedance analyzer results.Results: After taking <i>Saenggangunbi-tang</i> extract for approximately two months, with concomitant adjustments to exercise and diet, the serum levels of liver enzymes and triglyceride were decreased and the patient’s body weight, body mass index, hepatic steatosis index, and visceral fat area were also reduced. In addition, symptoms including fatigue and dyspepsia improved.Conclusion: This study suggests that <i>Saenggangunbi-tang</i> extract with exercise and a regulated diet could be a helpful treatment strategy for managing nonalcoholic fatty liver disease with metabolic disorders.
Published Version (
Free)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call